Bank of New York Mellon’s Achieve Life Sciences ACHV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-80,357
| Closed | -$215K | – | 4117 |
|
2025
Q1 | $215K | Buy |
80,357
+2,585
| +3% | +$6.9K | ﹤0.01% | 3841 |
|
2024
Q4 | $274K | Buy |
77,772
+555
| +0.7% | +$1.95K | ﹤0.01% | 3805 |
|
2024
Q3 | $366K | Sell |
77,217
-25,338
| -25% | -$120K | ﹤0.01% | 3658 |
|
2024
Q2 | $482K | Buy |
+102,555
| New | +$482K | ﹤0.01% | 3596 |
|
2024
Q1 | – | Sell |
-11,441
| Closed | -$47.1K | – | 4143 |
|
2023
Q4 | $47.1K | Hold |
11,441
| – | – | ﹤0.01% | 4154 |
|
2023
Q3 | $49.2K | Hold |
11,441
| – | – | ﹤0.01% | 4154 |
|
2023
Q2 | $59.4K | Sell |
11,441
-231
| -2% | -$1.2K | ﹤0.01% | 4142 |
|
2023
Q1 | $79.4K | Buy |
+11,672
| New | +$79.4K | ﹤0.01% | 4106 |
|
2017
Q3 | – | Sell |
-62,846
| Closed | -$22K | – | 4262 |
|
2017
Q2 | $22K | Buy |
62,846
+8,598
| +16% | +$3.01K | ﹤0.01% | 4222 |
|
2017
Q1 | $24K | Buy |
54,248
+18,504
| +52% | +$8.19K | ﹤0.01% | 4213 |
|
2016
Q4 | $18K | Sell |
35,744
-1,129
| -3% | -$569 | ﹤0.01% | 4220 |
|
2016
Q3 | $19K | Sell |
36,873
-6,333
| -15% | -$3.26K | ﹤0.01% | 4218 |
|
2016
Q2 | $43K | Hold |
43,206
| – | – | ﹤0.01% | 4195 |
|
2016
Q1 | $30K | Hold |
43,206
| – | – | ﹤0.01% | 4138 |
|
2015
Q4 | $52K | Sell |
43,206
-28
| -0.1% | -$34 | ﹤0.01% | 4144 |
|
2015
Q3 | $96K | Buy |
43,234
+24,388
| +129% | +$54.2K | ﹤0.01% | 4075 |
|
2015
Q2 | $44K | Buy |
18,846
+1,713
| +10% | +$4K | ﹤0.01% | 4166 |
|
2015
Q1 | $37K | Hold |
17,133
| – | – | ﹤0.01% | 4150 |
|
2014
Q4 | $39K | Buy |
17,133
+1
| +0% | +$2 | ﹤0.01% | 4144 |
|
2014
Q3 | $46K | Hold |
17,132
| – | – | ﹤0.01% | 4134 |
|
2014
Q2 | $64K | Sell |
17,132
-47,094
| -73% | -$176K | ﹤0.01% | 4047 |
|
2014
Q1 | $755K | Buy |
64,226
+1,801
| +3% | +$21.2K | ﹤0.01% | 3412 |
|
2013
Q4 | $520K | Buy |
62,425
+1,818
| +3% | +$15.1K | ﹤0.01% | 3561 |
|
2013
Q3 | $562K | Sell |
60,607
-13
| -0% | -$121 | ﹤0.01% | 3468 |
|
2013
Q2 | $594K | Buy |
+60,620
| New | +$594K | ﹤0.01% | 3420 |
|